C19orf12 and neuroblastoma: Western blottings performed in patients’ fibroblasts (p.Glu91*, p.Lys71*) [9] or KI neuroblastoma lines (p.Pro81Trefs*9) [47] show a strong reduction or even the complete absence of the protein, suggesting an effect of the variants on the total amount of C19orf12 protein.